ALZN vs HOOD · $2.4M cap vs P/E 48, rev $2.38B
Alzamend Neuro Inc (ALZN) versus Robinhood Markets Inc (HOOD) — a side-by-side from cached financials, not a winner call.
Alzamend Neuro Inc (ALZN) is a biotechnology company listed on US.
Robinhood Markets Inc (HOOD) is a capital markets company listed on NASDAQ. It is led by Vladimir Tenev.
ALZN does not have a complete income-statement cache yet.
Latest reported HOOD revenue for 2026-06-30 was $2.38B. Net income was $911.0M. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
ALZN currently screens at market cap $2.4M. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
Not investment advice. Open the ALZN and HOOD stock pages for the full models.
Not investment advice.